137 related articles for article (PubMed ID: 23892089)
21. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
Zhu ML; Hua RX; Zheng L
Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
[TBL] [Abstract][Full Text] [Related]
22. Association of XPC Gene Polymorphisms with Prostate Cancer Risk.
Kahnamouei SA; Narouie B; Sotoudeh M; Mollakouchekian MJ; Simforoosh N; Ziaee SA; Samzadeh M; Afshari M; Jamaldini SH; Imeni M; Hasanzad M
Clin Lab; 2016; 62(6):1009-15. PubMed ID: 27468562
[TBL] [Abstract][Full Text] [Related]
23. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.
Li SX; Dai QS; Chen SX; Zhang SD; Liao XY; Deng X; Chi HB; Li FJ; Zhu JH; Jiang YY
Tumour Biol; 2014 Apr; 35(4):3905-15. PubMed ID: 24347488
[TBL] [Abstract][Full Text] [Related]
24. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
25. Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.
Zou YF; Tao JH; Ye QL; Pan HF; Pan FM; Su H; Ye DQ
Genet Test Mol Biomarkers; 2013 Dec; 17(12):926-31. PubMed ID: 24093803
[TBL] [Abstract][Full Text] [Related]
26. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism.
Khan SG; Metter EJ; Tarone RE; Bohr VA; Grossman L; Hedayati M; Bale SJ; Emmert S; Kraemer KH
Carcinogenesis; 2000 Oct; 21(10):1821-5. PubMed ID: 11023539
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk.
Shore RE; Zeleniuch-Jacquotte A; Currie D; Mohrenweiser H; Afanasyeva Y; Koenig KL; Arslan AA; Toniolo P; Wirgin I
Int J Cancer; 2008 May; 122(9):2101-5. PubMed ID: 18196582
[TBL] [Abstract][Full Text] [Related]
28. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study.
Shen H; Sturgis EM; Khan SG; Qiao Y; Shahlavi T; Eicher SA; Xu Y; Wang X; Strom SS; Spitz MR; Kraemer KH; Wei Q
Cancer Res; 2001 Apr; 61(8):3321-5. PubMed ID: 11309287
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
[TBL] [Abstract][Full Text] [Related]
30. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
[TBL] [Abstract][Full Text] [Related]
31. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
Wang Y; Li Z; Liu N; Zhang G
Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
[TBL] [Abstract][Full Text] [Related]
32. XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.
Gangwar R; Mandhani A; Mittal RD
J Cancer Res Clin Oncol; 2010 May; 136(5):779-86. PubMed ID: 19924443
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
34. DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population.
Samara M; Papathanassiou M; Mitrakas L; Koukoulis G; Vlachostergios PJ; Tzortzis V
Curr Oncol; 2021 May; 28(3):1879-1885. PubMed ID: 34068981
[TBL] [Abstract][Full Text] [Related]
35. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
[TBL] [Abstract][Full Text] [Related]
36. Associations between XPC expression, genotype, and the risk of head and neck cancer.
Yang M; Kang MJ; Choi Y; Kim CS; Lee SM; Park CW; Lee HS; Tae K
Environ Mol Mutagen; 2005 May; 45(4):374-9. PubMed ID: 15657918
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
Liu C; Yin Q; Hu J; Li L; Zhang Y; Wang Y
Tumour Biol; 2013 Apr; 34(2):1205-13. PubMed ID: 23381646
[TBL] [Abstract][Full Text] [Related]
39. [Polymorphisms of the DNA repair genes XRCC1 and XPC: relationship to pancreatic cancer risk].
Wang L; Lin DX; Lu XH; Miao XP; Li H
Wei Sheng Yan Jiu; 2006 Sep; 35(5):534-6. PubMed ID: 17086695
[TBL] [Abstract][Full Text] [Related]
40. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma.
Yang ZH; Liang WB; Jia J; Wei YS; Zhou B; Zhang L
Acta Oncol; 2008; 47(3):379-84. PubMed ID: 17882560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
